Webinar covering the top items to consider when thinking about offering TMS in your practice, including but not limited to: a technological overview, clinical data, operational considerations, financial options, practice support factors, and more.
Justin and Bryce Gammill
TMS Clinical Solutions
Webinar covering the latest in clinical publications for obsessive-compulsive disorder, including but not limited to: post-marketing data, durability, co-morbidity with MDD, comparisons of the H7 Coil to Figure-8 Coil designs, and cost-effectiveness.
Dr. Aron Tendler, MD, CBSM
BrainsWay
Join Key Opinion Leader (KOL) Shan H. Siddiqi, MD (Harvard Medical School) who will discuss the current treatment landscape and unmet medical need in treating patients with anxious depression along with the BrainsWay management team who will discuss BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS™).
Shan H. Siddiqi, MD
Harvard Medical School and BrainsWay
Webinar covering the background of anxious depression as a condition, current treatment options, BrainsWay's clinical efficacy and Deep TMS protocol, comparisons to Figure-8 and medication studies, how to think about patient identification, and more.
Dr. Aron Tendler, MD, CBSM
BrainsWay
Join us to discuss market access and OCD provider resources to drive demand. Other topics include best practices, evidence, coverage drivers, influencers, and more, as well as our resource center to assist with prior authorizations and appeals.
Scott Blackman
BrainsWay
Join Key Opinion Leader (KOL) Kimberly Cress, M.D. (Greenbrook TMS NeuroHealth Centers) and BrainsWay's Chief Medical Officer, Dr. Aron Tendler to discuss the current OCD treatment landscape, BrainsWay's Deep TMS™ therapy, and a robust body of clinical evidence.
Kimberly Cress, M.D. and Aron Tendler, M.D.
Greenbrook TMS and BrainsWay
